Kabwama, Steven N.
Kiwanuka, Suzanne N.
Mapatano, Mala Ali
Fawole, Olufunmilayo I.
Seck, Ibrahima
Namale, Alice
Ndejjo, Rawlance
Kizito, Susan
Monje, Fred
Bosonkie, Marc
Egbende, Landry
Bello, Segun
Bamgboye, Eniola A.
Dairo, Magbagbeola D.
Adebowale, Ayo S.
Salawu, Mobolaji M.
Afolabi, Rotimi F.
Diallo, Issakha
Leye, Mamadou M. M.
Ndiaye, Youssou
Fall, Mane
Bassoum, Oumar
Alfvén, Tobias
Sambisa, William
Wanyenze, Rhoda K.
Funding for this research was provided by:
Bill and Melinda Gates Foundation
Article History
Received: 11 May 2022
Accepted: 7 June 2022
First Online: 15 June 2022
Declarations
:
: All key informants provided consent prior to conducting study procedures. This work was part of the Bill and Melinda Gates Foundation and Gates Venture funded “Assessment of the COVID-19 Response in the DRC, Nigeria, Senegal and Uganda” project for which each participating country obtained ethical approval to conduct the study. In Uganda, the study obtained ethical approval from the Makerere University School of Public Health Higher Degrees Research and Ethics Committee (HDRC #903) and was registered with the Uganda National Council for Science and Technology (UNCST #HS1121ES). In the DRC, the study was approved by the Kinshasa School of Public Health Ethics Committee. In Nigeria, the study was approved by National Health Research Ethics Committee and in Senegal by the National Committee of Ethics and Research. The research protocols and data collection tools were written in English and translated into French for use in the Francophone countries (DRC and Senegal) to ease data collection and align with country administrative and cultural requirements.
: Not applicable.
: All authors declare that they have no competing interests.